SERTRALINE HYDROCHLORIDE

SERTRALINE HYDROCHLORIDE was reported 119291 times

SERTRALINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MULTIPLE ACYL-COENZYME A DEHYDROGENASE DEFICIENCY 110 0.2576
1 PULMONARY VASCULITIS 91 0.1691
2 FEELING GUILTY 202 0.1530
3 AMAUROSIS FUGAX 164 0.1523
4 FEELINGS OF WORTHLESSNESS 198 0.1516
5 MATERNAL EXPOSURE TIMING UNSPECIFIED 548 0.1457
6 TRANSPOSITION OF THE GREAT VESSELS 89 0.1137
7 PHOBIA 93 0.0814
8 PATENT DUCTUS ARTERIOSUS 310 0.0780
9 NEGATIVE THOUGHTS 218 0.0744
10 HEART DISEASE CONGENITAL 259 0.0731
11 NEURITIS 100 0.0647
12 VENTRICULAR SEPTAL DEFECT 368 0.0642
13 ATRIAL SEPTAL DEFECT 528 0.0630
14 CLEFT PALATE 121 0.0626
15 TALIPES 194 0.0624
16 CONGENITAL ANOMALY 470 0.0607
17 DECREASED INTEREST 358 0.0606
18 CONJUNCTIVITIS ALLERGIC 86 0.0580
19 HOMICIDAL IDEATION 228 0.0562
20 HALLUCINATIONS, MIXED 233 0.0553
21 DRUG SCREEN FALSE POSITIVE 140 0.0505
22 PSYCHOMOTOR SKILLS IMPAIRED 131 0.0500
23 SEROTONIN SYNDROME 949 0.0494
24 BILIARY DYSKINESIA 83 0.0489
25 OBSESSIVE THOUGHTS 87 0.0482
26 ESSENTIAL HYPERTENSION 88 0.0480
27 NEONATAL RESPIRATORY DISTRESS SYNDROME 170 0.0480
28 FLAT AFFECT 111 0.0479
29 TENSION 291 0.0477
30 PSYCHIATRIC DECOMPENSATION 92 0.0470
31 ANORGASMIA 125 0.0460
32 BRUXISM 246 0.0456
33 OBSESSIVE-COMPULSIVE DISORDER 356 0.0443
34 PSYCHIATRIC SYMPTOM 320 0.0433
35 MAJOR DEPRESSION 310 0.0424
36 DIABETIC NEUROPATHY 206 0.0416
37 CHOLECYSTITIS CHRONIC 276 0.0412
38 BIPOLAR I DISORDER 90 0.0410
39 SELF INJURIOUS BEHAVIOUR 125 0.0409
40 URINARY TRACT DISORDER 182 0.0404
41 GAMBLING DISORDER 109 0.0403
42 APATHY 585 0.0401
43 DILATATION VENTRICULAR 83 0.0394
44 TACHYPHRENIA 136 0.0392
45 PRE-EXISTING CONDITION IMPROVED 245 0.0392
46 HYPOMANIA 144 0.0391
47 APPETITE DISORDER 257 0.0387
48 POST-TRAUMATIC STRESS DISORDER 259 0.0386
49 SUICIDAL BEHAVIOUR 159 0.0382
50 TEARFULNESS 161 0.0374
51 HOSTILITY 93 0.0366
52 PERSONALITY DISORDER 95 0.0362
53 DIABETIC COMA 101 0.0360
54 SEXUAL DYSFUNCTION 417 0.0355
55 NEPHROGENIC ANAEMIA 162 0.0349
56 DEPRESSION SUICIDAL 121 0.0349
57 FORCED EXPIRATORY VOLUME DECREASED 99 0.0349
58 BIPOLAR DISORDER 378 0.0347
59 VENTRICULAR HYPERTROPHY 86 0.0342
60 IMPULSIVE BEHAVIOUR 128 0.0341
61 HYPERPARATHYROIDISM SECONDARY 85 0.0339
62 HYPERLIPIDAEMIA 403 0.0337
63 TRICUSPID VALVE INCOMPETENCE 267 0.0336
64 DEPRESSIVE SYMPTOM 118 0.0334
65 PARANOIA 574 0.0333
66 RESPIRATORY SYMPTOM 94 0.0330
67 PANIC DISORDER 128 0.0330
68 SELF-INJURIOUS IDEATION 138 0.0329
69 OBESITY 520 0.0326
70 NORMOCHROMIC NORMOCYTIC ANAEMIA 97 0.0323
71 INTENTIONAL SELF-INJURY 651 0.0322
72 SOCIAL AVOIDANT BEHAVIOUR 186 0.0321
73 LOSS OF EMPLOYMENT 96 0.0318
74 HALLUCINATION, AUDITORY 504 0.0317
75 YAWNING 84 0.0315
76 BREATH SOUNDS ABNORMAL 152 0.0308
77 MANIA 506 0.0307
78 SUICIDAL IDEATION 2800 0.0306
79 ELECTRIC SHOCK SENSATION 85 0.0303
80 PANIC ATTACK 1087 0.0298
81 ALCOHOL USE 110 0.0298
82 SUICIDE ATTEMPT 1798 0.0296
83 HAEMORRHAGIC STROKE 231 0.0296
84 SNORING 108 0.0285
85 CARDIAC MURMUR 246 0.0284
86 THERMAL BURN 200 0.0282
87 DEPRESSION 6372 0.0280
88 AORTIC VALVE INCOMPETENCE 119 0.0279
89 ANXIETY DISORDER 93 0.0278
90 CRYING 1011 0.0278
91 ARTERIOSCLEROSIS CORONARY ARTERY 184 0.0277
92 THINKING ABNORMAL 517 0.0277
93 RHINITIS ALLERGIC 122 0.0274
94 TYPE 2 DIABETES MELLITUS 913 0.0271
95 SLEEP APNOEA SYNDROME 513 0.0269
96 MULTIPLE DRUG OVERDOSE 132 0.0266
97 ENURESIS 107 0.0265
98 TIC 144 0.0264
99 TYPE 1 DIABETES MELLITUS 159 0.0264
100 AFFECTIVE DISORDER 206 0.0262
101 FAILURE TO THRIVE 135 0.0260
102 MATERNAL DRUGS AFFECTING FOETUS 198 0.0258
103 COLITIS MICROSCOPIC 121 0.0255
104 DRUG SCREEN POSITIVE 201 0.0254
105 OTITIS MEDIA 84 0.0254
106 HYPERREFLEXIA 88 0.0252
107 SOMNAMBULISM 165 0.0251
108 PERSONALITY CHANGE 232 0.0249
109 PANIC REACTION 180 0.0249
110 SOPOR 328 0.0247
111 ANGER 836 0.0247
112 DIFFICULTY IN WALKING 84 0.0244
113 INFARCTION 167 0.0244
114 AKATHISIA 332 0.0243
115 NEUROLOGICAL SYMPTOM 139 0.0243
116 ECONOMIC PROBLEM 368 0.0243
117 CARDIOMEGALY 295 0.0240
118 ALCOHOLISM 102 0.0238
119 RESTLESSNESS 869 0.0237
120 HYPERACUSIS 88 0.0236
121 PSYCHOTIC DISORDER 696 0.0235
122 GRAND MAL CONVULSION 217 0.0235
123 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 97 0.0233
124 INTERVERTEBRAL DISC DEGENERATION 215 0.0232
125 FEELING OF DESPAIR 108 0.0231
126 PHOTOPHOBIA 434 0.0231
127 PRODUCT ADMINISTRATION INTERRUPTED 181 0.0230
128 ABNORMAL BEHAVIOUR 909 0.0229
129 ANXIETY 6495 0.0228
130 HYPERPHAGIA 91 0.0228
131 MITRAL VALVE INCOMPETENCE 257 0.0227
132 ARTERIOSCLEROSIS 213 0.0226
133 DYSPHORIA 114 0.0225
134 AGGRESSION 1127 0.0225
135 DELUSION 348 0.0224
136 RESTLESS LEGS SYNDROME 406 0.0223
137 LEFT VENTRICULAR HYPERTROPHY 95 0.0222
138 DISTURBANCE IN ATTENTION 1197 0.0222
139 OCULAR DISCOMFORT 248 0.0221
140 BRADYPHRENIA 144 0.0220
141 DRUG TOLERANCE 111 0.0219
142 DYSPHEMIA 95 0.0216
143 GESTATIONAL DIABETES 103 0.0216
144 SPINAL OSTEOARTHRITIS 189 0.0215
145 FAECAL INCONTINENCE 103 0.0214
146 BLOOD PROLACTIN INCREASED 101 0.0214
147 ATELECTASIS 205 0.0212
148 DISSOCIATION 162 0.0211
149 IRRITABILITY 1259 0.0209
150 BLOOD TRIGLYCERIDES INCREASED 368 0.0208
151 BLOOD CHOLESTEROL INCREASED 968 0.0207
152 TRISMUS 107 0.0207
153 CANDIDIASIS 83 0.0207
154 HEAD DISCOMFORT 366 0.0207
155 NEUROLEPTIC MALIGNANT SYNDROME 245 0.0206
156 ANOREXIA 264 0.0205
157 FEAR 551 0.0205
158 AGITATION 1504 0.0205
159 COORDINATION ABNORMAL 282 0.0202
160 MUSCLE TWITCHING 466 0.0202
161 ACTIVITIES OF DAILY LIVING IMPAIRED 400 0.0202
162 DENTAL CARIES 223 0.0201
163 NERVOUSNESS 1049 0.0201
164 WITHDRAWAL SYNDROME 843 0.0201
165 MYDRIASIS 256 0.0199
166 LOSS OF LIBIDO 179 0.0199
167 NIGHTMARE 688 0.0199
168 DEPRESSED MOOD 1045 0.0197
169 PSYCHOLOGICAL TRAUMA 170 0.0197
170 EMOTIONAL DISORDER 607 0.0197
171 FEELING DRUNK 146 0.0196
172 PARKINSONISM 191 0.0196
173 VISUAL DISTURBANCE 112 0.0195
174 DRUG EXPOSURE DURING PREGNANCY 663 0.0195
175 EYE MOVEMENT DISORDER 133 0.0194
176 FULL BLOOD COUNT ABNORMAL 205 0.0194
177 PRESYNCOPE 469 0.0193
178 MENTAL DISORDER 826 0.0190
179 BUNDLE BRANCH BLOCK RIGHT 87 0.0189
180 HALLUCINATION, VISUAL 399 0.0189
181 INTENTIONAL OVERDOSE 1212 0.0189
182 FEELING JITTERY 359 0.0188
183 PRE-ECLAMPSIA 89 0.0187
184 EUPHORIC MOOD 191 0.0186
185 STOMACH DISCOMFORT 96 0.0186
186 PULMONARY ALVEOLAR HAEMORRHAGE 104 0.0185
187 OBSTRUCTIVE AIRWAYS DISORDER 205 0.0184
188 SPINAL COLUMN STENOSIS 87 0.0184
189 PULMONARY FIBROSIS 352 0.0183
190 ABNORMAL DREAMS 505 0.0183
191 CARPAL TUNNEL SYNDROME 256 0.0183
192 GLUCOSE TOLERANCE IMPAIRED 108 0.0182
193 DIABETES MELLITUS 1389 0.0182
194 BLOOD CHOLESTEROL ABNORMAL 84 0.0182
195 DIVERTICULUM 129 0.0181
196 COELIAC DISEASE 178 0.0181
197 HYPERVENTILATION 105 0.0181
198 GENERALISED OEDEMA 224 0.0181
199 OVERWEIGHT 97 0.0180
200 DYSKINESIA 732 0.0180
201 INITIAL INSOMNIA 184 0.0179
202 TREMOR 2963 0.0178
203 MOOD SWINGS 566 0.0177
204 HYPERSOMNIA 509 0.0177
205 RECALLED PRODUCT ADMINISTERED 169 0.0177
206 ANHEDONIA 465 0.0177
207 HIATUS HERNIA 228 0.0176
208 CONVULSION 1007 0.0176
209 MIDDLE INSOMNIA 328 0.0175
210 BRADYKINESIA 103 0.0174
211 DRUG INTERACTION 2767 0.0174
212 HYPERCHOLESTEROLAEMIA 168 0.0174
213 HALLUCINATION 1299 0.0172
214 URINARY INCONTINENCE 510 0.0172
215 FIBROMYALGIA 418 0.0172
216 RENAL FAILURE CHRONIC 132 0.0171
217 POISONING DELIBERATE 162 0.0171
218 ELECTROCARDIOGRAM ABNORMAL 134 0.0171
219 TINNITUS 783 0.0170
220 VITAMIN D DEFICIENCY 166 0.0170
221 INCOHERENT 110 0.0170
222 GALLBLADDER DISORDER 303 0.0170
223 RHEUMATOID FACTOR POSITIVE 98 0.0169
224 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 174 0.0169
225 DYSLIPIDAEMIA 86 0.0169
226 INSOMNIA 4510 0.0169
227 ALTERED STATE OF CONSCIOUSNESS 365 0.0168
228 FORMICATION 117 0.0168
229 AMNESIA 1093 0.0168
230 HYPOTHYROIDISM 535 0.0167
231 SEASONAL ALLERGY 237 0.0167
232 PSYCHOMOTOR HYPERACTIVITY 277 0.0167
233 SEDATION 435 0.0166
234 MATERNAL EXPOSURE DURING PREGNANCY 1478 0.0166
235 MUSCLE RIGIDITY 198 0.0165
236 INFUSION SITE SWELLING 104 0.0165
237 DISORIENTATION 651 0.0164
238 SCREAMING 104 0.0163
239 PERIPHERAL VASCULAR DISORDER 84 0.0163
240 DIPLOPIA 423 0.0163
241 MYOCLONUS 194 0.0163
242 MENTAL IMPAIRMENT 393 0.0162
243 UTERINE PERFORATION 137 0.0162
244 LACERATION 152 0.0161
245 ERECTILE DYSFUNCTION 415 0.0161
246 DRUG TOXICITY 220 0.0161
247 INCONTINENCE 170 0.0161
248 JAW DISORDER 88 0.0161
249 SKIN WARM 93 0.0160
250 SCOLIOSIS 98 0.0158
251 HEPATIC STEATOSIS 294 0.0158
252 DIABETES MELLITUS INADEQUATE CONTROL 279 0.0157
253 MUSCLE TIGHTNESS 255 0.0157
254 VITAMIN D DECREASED 133 0.0155
255 METABOLIC DISORDER 90 0.0155
256 RENAL CYST 123 0.0155
257 HAEMATOCRIT DECREASED 307 0.0155
258 FLANK PAIN 145 0.0155
259 RED BLOOD CELL SEDIMENTATION RATE INCREASED 171 0.0154
260 INTERVERTEBRAL DISC PROTRUSION 337 0.0154
261 NIGHT SWEATS 496 0.0154
262 PRESCRIBED OVERDOSE 297 0.0153
263 HAEMATEMESIS 389 0.0153
264 HAEMORRHOIDS 299 0.0153
265 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 736 0.0153
266 SWOLLEN TONGUE 478 0.0153
267 ATAXIA 181 0.0152
268 MOOD ALTERED 415 0.0152
269 TONGUE DISORDER 110 0.0152
270 SCHIZOPHRENIA 184 0.0151
271 GASTROOESOPHAGEAL REFLUX DISEASE 1218 0.0151
272 GALACTORRHOEA 97 0.0151
273 CHOLELITHIASIS 495 0.0151
274 IRON DEFICIENCY ANAEMIA 139 0.0150
275 TOOTH ABSCESS 153 0.0150
276 WRIST FRACTURE 180 0.0150
277 MENTAL STATUS CHANGES 413 0.0149
278 EMPHYSEMA 150 0.0149
279 PREMATURE LABOUR 84 0.0148
280 CONCUSSION 115 0.0148
281 HEARING IMPAIRED 89 0.0148
282 HEAD INJURY 469 0.0148
283 BODY HEIGHT DECREASED 158 0.0148
284 ENERGY INCREASED 87 0.0147
285 VERTIGO 898 0.0147
286 END STAGE RENAL DISEASE 268 0.0147
287 IMPAIRED DRIVING ABILITY 167 0.0147
288 SOMNOLENCE 2958 0.0147
289 HYPONATRAEMIA 827 0.0147
290 CAESAREAN SECTION 170 0.0146
291 INFUSION SITE ERYTHEMA 123 0.0146
292 PREMATURE BABY 439 0.0146
293 STAPHYLOCOCCAL INFECTION 481 0.0146
294 COMPLETED SUICIDE 1215 0.0146
295 REFUSAL OF TREATMENT BY PATIENT 95 0.0145
296 TARDIVE DYSKINESIA 410 0.0145
297 INJURY 1020 0.0145
298 SINUS HEADACHE 86 0.0145
299 ORTHOSTATIC HYPOTENSION 252 0.0145
300 ANGINA UNSTABLE 94 0.0144
301 MUSCLE STRAIN 125 0.0144
302 FEELING ABNORMAL 3438 0.0143
303 IMPAIRED WORK ABILITY 305 0.0143
304 CONFUSIONAL STATE 2289 0.0141
305 BALANCE DISORDER 1221 0.0141
306 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 737 0.0141
307 WEIGHT INCREASED 3160 0.0141
308 OSTEOPENIA 213 0.0140
309 AFFECT LABILITY 135 0.0140
310 CHOLECYSTECTOMY 160 0.0140
311 SPEECH DISORDER 732 0.0140
312 BLOOD PRESSURE DIASTOLIC DECREASED 103 0.0139
313 FOOT FRACTURE 263 0.0139
314 CORONARY ARTERY DISEASE 420 0.0139
315 DEVELOPMENTAL DELAY 125 0.0138
316 HYPERHIDROSIS 1785 0.0138
317 PRODUCTIVE COUGH 658 0.0138
318 BRAIN INJURY 138 0.0137
319 HAIR DISORDER 113 0.0137
320 COMA 652 0.0137
321 BLOOD SODIUM DECREASED 258 0.0137
322 DRUG ABUSER 84 0.0137
323 EATING DISORDER 290 0.0136
324 DYSTONIA 264 0.0136
325 SLUGGISHNESS 138 0.0135
326 EAR PAIN 263 0.0135
327 DIZZINESS POSTURAL 131 0.0135
328 ANKLE FRACTURE 209 0.0135
329 OSTEOARTHRITIS 571 0.0135
330 SINUS BRADYCARDIA 130 0.0134
331 DYSARTHRIA 506 0.0134
332 POOR QUALITY SLEEP 289 0.0134
333 ASPIRATION 147 0.0134
334 RIB FRACTURE 276 0.0134
335 TENDERNESS 139 0.0133
336 IMPAIRED GASTRIC EMPTYING 181 0.0133
337 SLEEP DISORDER 937 0.0133
338 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 225 0.0132
339 VENTRICULAR EXTRASYSTOLES 137 0.0132
340 ROAD TRAFFIC ACCIDENT 551 0.0132
341 TREATMENT NONCOMPLIANCE 719 0.0131
342 ROTATOR CUFF SYNDROME 168 0.0131
343 SENSATION OF FOREIGN BODY 110 0.0130
344 GASTRITIS 343 0.0130
345 MULTIPLE ALLERGIES 102 0.0130
346 OVARIAN CYST 130 0.0130
347 MOTOR DYSFUNCTION 132 0.0129
348 HYSTERECTOMY 112 0.0129
349 FALL 4295 0.0129
350 DYSGRAPHIA 85 0.0129
351 NERVE INJURY 143 0.0128
352 EYE PAIN 725 0.0128
353 SUPRAVENTRICULAR TACHYCARDIA 123 0.0128
354 COGNITIVE DISORDER 599 0.0128
355 SALIVARY HYPERSECRETION 128 0.0128
356 SENSORY DISTURBANCE 205 0.0128
357 COLD SWEAT 225 0.0128
358 SINUS TACHYCARDIA 181 0.0127
359 DROOLING 88 0.0127
360 SCAR 218 0.0127
361 PULMONARY HYPERTENSION 265 0.0127
362 GASTROENTERITIS VIRAL 229 0.0127
363 UPPER RESPIRATORY TRACT INFECTION 584 0.0126
364 DRY MOUTH 1021 0.0126
365 POISONING 158 0.0126
366 LARGE INTESTINE POLYP 87 0.0125
367 MIGRAINE 1198 0.0125
368 FACIAL PAIN 112 0.0125
369 ECCHYMOSIS 86 0.0125
370 LETHARGY 721 0.0125
371 SINUS DISORDER 248 0.0125
372 SKIN LACERATION 136 0.0125
373 MEMORY IMPAIRMENT 1718 0.0125
374 NODULE 163 0.0125
375 RESPIRATORY ARREST 344 0.0125
376 INCREASED APPETITE 238 0.0124
377 BLOOD POTASSIUM DECREASED 374 0.0124
378 MALNUTRITION 139 0.0124
379 BACK INJURY 135 0.0124
380 HYPERGLYCAEMIA 452 0.0124
381 UNRESPONSIVE TO STIMULI 320 0.0124
382 DECUBITUS ULCER 101 0.0124
383 LUNG INFILTRATION 109 0.0123
384 WEIGHT FLUCTUATION 129 0.0123
385 WHEEZING 731 0.0123
386 UTERINE LEIOMYOMA 90 0.0123
387 RETCHING 262 0.0123
388 INFUSION SITE PAIN 158 0.0122
389 CONTUSION 1174 0.0122
390 JOINT INJURY 260 0.0122
391 VASCULITIS 141 0.0121
392 PHARMACEUTICAL PRODUCT COMPLAINT 314 0.0121
393 NECK PAIN 675 0.0121
394 BONE DISORDER 220 0.0121
395 PAIN IN JAW 342 0.0121
396 TOOTH FRACTURE 133 0.0121
397 HYPOKINESIA 175 0.0120
398 SYNCOPE 1204 0.0120
399 ULCER 191 0.0120
400 DEMENTIA 335 0.0120
401 LOSS OF CONSCIOUSNESS 1532 0.0119
402 LIGAMENT SPRAIN 118 0.0119
403 PULMONARY EMBOLISM 1134 0.0119
404 HYPERAESTHESIA 98 0.0119
405 BREAST PAIN 127 0.0119
406 HEART RATE IRREGULAR 269 0.0119
407 OESOPHAGITIS 130 0.0119
408 BRONCHITIS 880 0.0119
409 SUBDURAL HAEMATOMA 170 0.0119
410 HYPOTONIA 118 0.0118
411 DECREASED ACTIVITY 127 0.0118
412 DRUG ABUSE 976 0.0117
413 HEPATOMEGALY 115 0.0117
414 THYROID DISORDER 180 0.0117
415 ANAL INCONTINENCE 105 0.0117
416 HEREDITARY ANGIOEDEMA 125 0.0116
417 MICTURITION URGENCY 133 0.0116
418 LOW DENSITY LIPOPROTEIN INCREASED 90 0.0116
419 IRRITABLE BOWEL SYNDROME 249 0.0116
420 MUSCLE DISORDER 94 0.0116
421 NERVE COMPRESSION 107 0.0116
422 BLOOD MAGNESIUM DECREASED 100 0.0116
423 PANCREATITIS 612 0.0116
424 BACK DISORDER 188 0.0116
425 OEDEMA PERIPHERAL 1408 0.0115
426 HYPOKALAEMIA 532 0.0115
427 ORAL PAIN 258 0.0115
428 CARDIOMYOPATHY 170 0.0115
429 MUSCULOSKELETAL CHEST PAIN 178 0.0115
430 SPINAL COMPRESSION FRACTURE 95 0.0115
431 TOOTHACHE 208 0.0115
432 PREGNANCY 230 0.0115
433 FOOT DEFORMITY 127 0.0114
434 SINUSITIS 1174 0.0114
435 PULMONARY CONGESTION 151 0.0114
436 CARDIO-RESPIRATORY ARREST 477 0.0114
437 TACHYCARDIA 1012 0.0114
438 CHRONIC KIDNEY DISEASE 864 0.0114
439 PALPITATIONS 1329 0.0113
440 PELVIC PAIN 206 0.0113
441 CHOLECYSTITIS 135 0.0113
442 APHASIA 342 0.0113
443 INCREASED TENDENCY TO BRUISE 104 0.0113
444 URINARY RETENTION 377 0.0113
445 EXOSTOSIS 103 0.0113
446 ANGINA PECTORIS 323 0.0113
447 WOUND 315 0.0113
448 ASTHENIA 4237 0.0113
449 SPLENOMEGALY 132 0.0113
450 EOSINOPHILIA 197 0.0112
451 PARAESTHESIA 1763 0.0112
452 METRORRHAGIA 191 0.0112
453 SPINAL DISORDER 106 0.0112
454 CHEST PAIN 2073 0.0112
455 DEEP VEIN THROMBOSIS 727 0.0112
456 HAEMOPTYSIS 312 0.0112
457 APNOEA 87 0.0112
458 PELVIC FRACTURE 87 0.0112
459 UPPER-AIRWAY COUGH SYNDROME 92 0.0112
460 DIZZINESS 5569 0.0112
461 BURSITIS 135 0.0111
462 BLOOD IRON DECREASED 132 0.0111
463 NOCTURIA 135 0.0111
464 DRUG LEVEL INCREASED 184 0.0111
465 VITREOUS FLOATERS 109 0.0111
466 CORONARY ARTERY OCCLUSION 152 0.0111
467 VISION BLURRED 1521 0.0111
468 WRONG TECHNIQUE IN DRUG USAGE PROCESS 402 0.0111
469 SCRATCH 116 0.0110
470 HYPOXIA 387 0.0110
471 HEADACHE 6885 0.0110
472 ELECTROCARDIOGRAM QT PROLONGED 395 0.0110
473 DYSPHAGIA 1041 0.0110
474 BLOOD UREA INCREASED 183 0.0109
475 SMALL INTESTINAL OBSTRUCTION 134 0.0109
476 QUALITY OF LIFE DECREASED 146 0.0109
477 DYSPHONIA 636 0.0109
478 POLYURIA 89 0.0109
479 NEPHROLITHIASIS 498 0.0108
480 URINARY TRACT INFECTION 1850 0.0108
481 HYPERTENSION 2292 0.0108
482 HYPOAESTHESIA 1619 0.0108
483 RENAL FAILURE ACUTE 459 0.0108
484 EAR DISCOMFORT 111 0.0108
485 DEHYDRATION 1436 0.0108
486 TEMPERATURE INTOLERANCE 111 0.0107
487 MENSTRUAL DISORDER 89 0.0107
488 GASTRIC ULCER 204 0.0107
489 INSURANCE ISSUE 164 0.0107
490 MIOSIS 86 0.0107
491 SENSORY LOSS 86 0.0107
492 CARDIAC FAILURE CONGESTIVE 857 0.0107
493 SCIATICA 170 0.0107
494 THERAPEUTIC RESPONSE UNEXPECTED 478 0.0106
495 DYSSTASIA 311 0.0106
496 MYOCARDIAL ISCHAEMIA 121 0.0106
497 HUNGER 148 0.0106
498 MOVEMENT DISORDER 341 0.0106
499 WEIGHT DECREASED 2954 0.0106
500 BEDRIDDEN 139 0.0106
501 BLADDER DISORDER 105 0.0106
502 SUBSTANCE ABUSE 86 0.0106
503 BLOOD CREATINE PHOSPHOKINASE INCREASED 304 0.0105
504 DYSPEPSIA 1038 0.0105
505 MENORRHAGIA 207 0.0105
506 UPPER LIMB FRACTURE 210 0.0105
507 HAEMATURIA 360 0.0105
508 KIDNEY INFECTION 206 0.0105
509 DYSURIA 385 0.0104
510 ASCITES 307 0.0104
511 PHARYNGITIS STREPTOCOCCAL 113 0.0104
512 NAUSEA 8257 0.0104
513 OSTEOPOROSIS 429 0.0104
514 HEART RATE INCREASED 1033 0.0104
515 RHINITIS 84 0.0104
516 ABASIA 257 0.0104
517 CELLULITIS 524 0.0104
518 EXTRAPYRAMIDAL DISORDER 258 0.0104
519 CHILLS 1217 0.0104
520 DRUG WITHDRAWAL SYNDROME 908 0.0103
521 HAIR COLOUR CHANGES 128 0.0103
522 DYSPNOEA EXERTIONAL 386 0.0102
523 BACK PAIN 2380 0.0102
524 PHOTOSENSITIVITY REACTION 169 0.0102
525 PANCREATITIS ACUTE 230 0.0102
526 IMPAIRED QUALITY OF LIFE 147 0.0102
527 PARAESTHESIA ORAL 147 0.0102
528 THIRST 182 0.0102
529 INTERNATIONAL NORMALISED RATIO INCREASED 290 0.0102
530 TOOTH INFECTION 134 0.0102
531 OSTEOMYELITIS 184 0.0102
532 PRODUCT SUBSTITUTION ISSUE 585 0.0102
533 PULMONARY MASS 151 0.0101
534 BLOOD PRESSURE INCREASED 1545 0.0101
535 VIRAL INFECTION 336 0.0101
536 CYSTITIS 321 0.0101
537 CYST 125 0.0101
538 TRANSIENT ISCHAEMIC ATTACK 339 0.0100
539 PNEUMONIA ASPIRATION 251 0.0100
540 ACUTE RESPIRATORY FAILURE 193 0.0100
541 ASTHMA 1132 0.0100
542 DIABETIC KETOACIDOSIS 240 0.0100
543 DECREASED APPETITE 2319 0.0100
544 FATIGUE 7759 0.0100
545 BODY TEMPERATURE DECREASED 98 0.0099
546 GAIT DISTURBANCE 1899 0.0099
547 SWELLING FACE 646 0.0099
548 RECTAL HAEMORRHAGE 426 0.0099
549 RESPIRATORY RATE INCREASED 88 0.0099
550 DEAFNESS 259 0.0099
551 LIMB INJURY 269 0.0099
552 CLOSTRIDIUM DIFFICILE COLITIS 105 0.0099
553 MYALGIA 1682 0.0099
554 MACULAR DEGENERATION 118 0.0099
555 PRESCRIBED UNDERDOSE 197 0.0099
556 INFLUENZA LIKE ILLNESS 812 0.0099
557 MUSCULOSKELETAL STIFFNESS 864 0.0099
558 POLLAKIURIA 411 0.0098
559 DERMATITIS CONTACT 112 0.0098
560 BLOOD PRESSURE SYSTOLIC INCREASED 191 0.0098
561 DELIRIUM 339 0.0098
562 VENTRICULAR TACHYCARDIA 161 0.0097
563 JOINT DISLOCATION 103 0.0097
564 FEELING COLD 271 0.0097
565 HAIR TEXTURE ABNORMAL 130 0.0097
566 ABDOMINAL PAIN 2259 0.0097
567 MUSCULOSKELETAL DISCOMFORT 167 0.0097
568 PULMONARY OEDEMA 434 0.0097
569 ORAL DISCOMFORT 134 0.0096
570 GASTROINTESTINAL PAIN 106 0.0096
571 MUSCLE SPASMS 1768 0.0096
572 POST PROCEDURAL COMPLICATION 185 0.0096
573 NERVOUS SYSTEM DISORDER 300 0.0096
574 BLINDNESS 391 0.0096
575 VOMITING 4502 0.0096
576 RESPIRATORY DISTRESS 264 0.0096
577 HYPOAESTHESIA ORAL 144 0.0095
578 ARTHRITIS 751 0.0095
579 RED BLOOD CELL COUNT DECREASED 272 0.0095
580 BRAIN FOG 149 0.0095
581 BLOOD ALKALINE PHOSPHATASE INCREASED 236 0.0095
582 PHARYNGEAL OEDEMA 146 0.0095
583 TACHYPNOEA 129 0.0095
584 TOOTH EXTRACTION 118 0.0095
585 DRUG WITHDRAWAL SYNDROME NEONATAL 140 0.0094
586 HIP FRACTURE 304 0.0094
587 TOOTH DISORDER 210 0.0094
588 MADAROSIS 109 0.0094
589 NEURALGIA 228 0.0094
590 NASAL CONGESTION 551 0.0094
591 LOWER LIMB FRACTURE 180 0.0094
592 CONDITION AGGRAVATED 2845 0.0093
593 DISABILITY 185 0.0093
594 EAR INFECTION 248 0.0093
595 GASTROENTERITIS 136 0.0093
596 BODY TEMPERATURE INCREASED 190 0.0093
597 OXYGEN SATURATION DECREASED 523 0.0093
598 DEPRESSED LEVEL OF CONSCIOUSNESS 368 0.0093
599 CHEST DISCOMFORT 948 0.0092
600 BURNING SENSATION 647 0.0092
601 FEELING HOT 565 0.0092
602 DRUG EFFECT DECREASED 496 0.0092
603 HEART RATE DECREASED 323 0.0092
604 RESPIRATORY TRACT CONGESTION 146 0.0092
605 ABDOMINAL PAIN UPPER 1890 0.0092
606 MUSCULAR WEAKNESS 1043 0.0092
607 BLOOD PRESSURE FLUCTUATION 220 0.0092
608 OROPHARYNGEAL PAIN 848 0.0092
609 WHITE BLOOD CELL COUNT INCREASED 351 0.0091
610 CONSTIPATION 1995 0.0091
611 SKIN ULCER 236 0.0091
612 ABDOMINAL DISCOMFORT 1531 0.0091
613 ORAL CANDIDIASIS 120 0.0091
614 CYANOSIS 143 0.0091
615 VAGINAL DISCHARGE 92 0.0091
616 RENAL FAILURE 1207 0.0091
617 GLAUCOMA 175 0.0091
618 HYPERCALCAEMIA 112 0.0091
619 MUSCULOSKELETAL PAIN 475 0.0091
620 SINUS CONGESTION 122 0.0090
621 FLUID RETENTION 457 0.0090
622 PAIN 5517 0.0090
623 CHOKING 175 0.0090
624 DRY THROAT 91 0.0089
625 DIARRHOEA 5764 0.0089
626 EMOTIONAL DISTRESS 1078 0.0089
627 AMENORRHOEA 156 0.0089
628 LEUKOCYTOSIS 161 0.0089
629 BLOOD CALCIUM DECREASED 100 0.0089
630 PNEUMOTHORAX 141 0.0089
631 GASTRIC DISORDER 305 0.0089
632 PHARYNGITIS 110 0.0089
633 RHABDOMYOLYSIS 369 0.0088
634 ASPARTATE AMINOTRANSFERASE INCREASED 470 0.0088
635 PERIPHERAL COLDNESS 121 0.0088
636 MUSCLE SPASTICITY 108 0.0088
637 SNEEZING 197 0.0088
638 COUGH 2459 0.0088
639 ARTHROPATHY 487 0.0088
640 DYSPNOEA 4945 0.0087
641 DRUG INTOLERANCE 842 0.0087
642 ELECTROLYTE IMBALANCE 101 0.0087
643 BLOOD POTASSIUM INCREASED 141 0.0087
644 RHINORRHOEA 561 0.0087
645 EPILEPSY 265 0.0087
646 JOINT RANGE OF MOTION DECREASED 116 0.0086
647 PAIN IN EXTREMITY 2540 0.0086
648 HOSPICE CARE 85 0.0086
649 THROAT IRRITATION 386 0.0086
650 IMPAIRED HEALING 282 0.0086
651 BLOOD URINE PRESENT 163 0.0086
652 HYPOTENSION 1720 0.0086
653 FLATULENCE 485 0.0085
654 THROAT TIGHTNESS 231 0.0085
655 OEDEMA 463 0.0085
656 DYSGEUSIA 634 0.0085
657 NO THERAPEUTIC RESPONSE 104 0.0085
658 CARDIAC ARREST 704 0.0085
659 DYSMENORRHOEA 113 0.0085
660 COAGULOPATHY 142 0.0085
661 ALANINE AMINOTRANSFERASE INCREASED 522 0.0085
662 HEMIPARESIS 144 0.0085
663 MALAISE 3717 0.0085
664 INTENTIONAL DRUG MISUSE 177 0.0085
665 JOINT STIFFNESS 222 0.0085
666 HAEMATOMA 219 0.0084
667 FLUSHING 859 0.0084
668 HYPOPHAGIA 216 0.0084
669 THROMBOSIS 679 0.0084
670 LOCAL SWELLING 147 0.0084
671 GENERALISED TONIC-CLONIC SEIZURE 139 0.0084
672 BLOOD PRESSURE DECREASED 557 0.0084
673 VENTRICULAR FIBRILLATION 93 0.0084
674 HOT FLUSH 629 0.0083
675 HERNIA 161 0.0083
676 BRAIN OEDEMA 105 0.0083
677 ACCIDENT 99 0.0083
678 RASH PRURITIC 449 0.0083
679 BASAL CELL CARCINOMA 129 0.0083
680 HYPOGLYCAEMIA 401 0.0083
681 ABDOMINAL DISTENSION 861 0.0082
682 RENAL INJURY 245 0.0082
683 PNEUMONIA 2660 0.0082
684 SKIN DISORDER 273 0.0082
685 EPISTAXIS 610 0.0081
686 UPPER GASTROINTESTINAL HAEMORRHAGE 137 0.0081
687 HEPATITIS 208 0.0081
688 FAECES DISCOLOURED 176 0.0081
689 SEIZURE 937 0.0081
690 ARRHYTHMIA 384 0.0081
691 SPINAL FRACTURE 162 0.0081
692 MULTIPLE SCLEROSIS 386 0.0081
693 PETECHIAE 84 0.0080
694 UNEVALUABLE EVENT 609 0.0080
695 UNINTENDED PREGNANCY 84 0.0080
696 RESPIRATORY TRACT INFECTION 209 0.0080
697 FOETAL EXPOSURE DURING PREGNANCY 652 0.0080
698 TOOTH LOSS 166 0.0080
699 ANAEMIA 1525 0.0080
700 ATRIAL FIBRILLATION 778 0.0080
701 BLOOD COUNT ABNORMAL 121 0.0080
702 PALLOR 216 0.0079
703 KNEE ARTHROPLASTY 167 0.0079
704 MULTIPLE SCLEROSIS RELAPSE 543 0.0079
705 RESPIRATORY DEPRESSION 97 0.0079
706 DRUG ERUPTION 140 0.0079
707 LUNG DISORDER 386 0.0079
708 ARTHRALGIA 3274 0.0079
709 DRY EYE 393 0.0079
710 ACUTE MYOCARDIAL INFARCTION 231 0.0078
711 RENAL DISORDER 365 0.0078
712 LIVER FUNCTION TEST ABNORMAL 227 0.0078
713 HEPATIC ENZYME INCREASED 531 0.0078
714 RESPIRATORY DISORDER 233 0.0078
715 EYE DISORDER 256 0.0078
716 HEPATITIS C 94 0.0078
717 PRODUCT TASTE ABNORMAL 105 0.0077
718 INFLUENZA 864 0.0077
719 BLOOD PRESSURE ABNORMAL 154 0.0077
720 SURGERY 454 0.0077
721 ABORTION SPONTANEOUS 309 0.0077
722 CARDIAC DISORDER 721 0.0077
723 HAEMOGLOBIN DECREASED 791 0.0077
724 GLOSSODYNIA 172 0.0077
725 SEPSIS 856 0.0077
726 PLATELET COUNT INCREASED 100 0.0077
727 CHROMATURIA 173 0.0077
728 MASS 107 0.0076
729 PERICARDIAL EFFUSION 177 0.0076
730 DIVERTICULITIS 212 0.0076
731 CENTRAL NERVOUS SYSTEM LESION 105 0.0076
732 BONE PAIN 446 0.0076
733 MENSTRUATION IRREGULAR 203 0.0076
734 SKIN DISCOLOURATION 348 0.0076
735 CLOSTRIDIUM DIFFICILE INFECTION 165 0.0076
736 BACTERIAL INFECTION 141 0.0076
737 ALOPECIA 1483 0.0075
738 MOUTH ULCERATION 159 0.0075
739 RESPIRATORY FAILURE 549 0.0075
740 ANGIOEDEMA 333 0.0075
741 DERMATITIS 157 0.0075
742 TOXICITY TO VARIOUS AGENTS 1263 0.0075
743 FLUID OVERLOAD 109 0.0075
744 DEVICE DISLOCATION 325 0.0075
745 EJECTION FRACTION DECREASED 116 0.0075
746 BRADYCARDIA 395 0.0074
747 MUSCLE ATROPHY 94 0.0074
748 MULTI-ORGAN FAILURE 128 0.0074
749 GAMMA-GLUTAMYLTRANSFERASE INCREASED 164 0.0074
750 PRURITUS GENERALISED 160 0.0074
751 FEMUR FRACTURE 229 0.0074
752 HYPERSENSITIVITY 1368 0.0074
753 FUNGAL INFECTION 245 0.0073
754 SPINAL PAIN 86 0.0073
755 ABSCESS 117 0.0073
756 NEUROPATHY PERIPHERAL 697 0.0073
757 SYNOVITIS 132 0.0073
758 CHOLESTASIS 140 0.0073
759 SWELLING 682 0.0073
760 IMMUNE SYSTEM DISORDER 96 0.0073
761 MOBILITY DECREASED 523 0.0073
762 ABDOMINAL PAIN LOWER 184 0.0073
763 DISEASE RECURRENCE 346 0.0073
764 SKIN FISSURES 142 0.0073
765 HYPERTHYROIDISM 105 0.0072
766 LYMPHOCYTE COUNT DECREASED 128 0.0072
767 HEPATIC CIRRHOSIS 136 0.0072
768 ILLNESS 745 0.0072
769 COMPLICATION ASSOCIATED WITH DEVICE 105 0.0072
770 SKIN HAEMORRHAGE 107 0.0072
771 POST PROCEDURAL HAEMORRHAGE 84 0.0072
772 GASTROINTESTINAL DISORDER 645 0.0072
773 VISUAL IMPAIRMENT 891 0.0072
774 SECRETION DISCHARGE 90 0.0072
775 SKIN LESION 197 0.0072
776 GYNAECOMASTIA 222 0.0072
777 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 393 0.0072
778 PARALYSIS 102 0.0071
779 CEREBROVASCULAR ACCIDENT 1204 0.0071
780 CANDIDA INFECTION 120 0.0071
781 NASOPHARYNGITIS 1306 0.0071
782 PRURITUS 2710 0.0070
783 VAGINAL HAEMORRHAGE 306 0.0070
784 TENDONITIS 109 0.0070
785 FREQUENT BOWEL MOVEMENTS 190 0.0070
786 PRODUCT DOSE OMISSION IN ERROR 199 0.0070
787 MYOCARDIAL INFARCTION 1222 0.0070
788 CATARACT 417 0.0070
789 HEPATIC CYTOLYSIS 89 0.0070
790 INJECTION SITE HAEMATOMA 101 0.0070
791 PROCEDURAL PAIN 193 0.0070
792 GASTROINTESTINAL HAEMORRHAGE 578 0.0069
793 OVERDOSE 1488 0.0069
794 MUSCULOSKELETAL DISORDER 131 0.0069
795 EYE SWELLING 255 0.0068
796 HAEMATOCHEZIA 378 0.0068
797 PLEURAL EFFUSION 416 0.0068
798 HYPOMAGNESAEMIA 95 0.0068
799 HERPES ZOSTER 391 0.0068
800 VISUAL ACUITY REDUCED 226 0.0068
801 COLITIS 257 0.0068
802 BLOOD CREATININE INCREASED 442 0.0068
803 INTENTIONAL DOSE OMISSION 193 0.0068
804 FEEDING DISORDER 137 0.0067
805 INTENTIONAL PRODUCT USE ISSUE 589 0.0067
806 BLINDNESS UNILATERAL 94 0.0067
807 JOINT SWELLING 798 0.0066
808 LIMB DISCOMFORT 204 0.0066
809 INFLAMMATION 339 0.0066
810 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 467 0.0066
811 BLOOD BILIRUBIN INCREASED 177 0.0065
812 HIP ARTHROPLASTY 100 0.0065
813 THERAPY CESSATION 335 0.0065
814 CIRCULATORY COLLAPSE 111 0.0065
815 ERUCTATION 126 0.0065
816 FULL BLOOD COUNT DECREASED 131 0.0065
817 DISCOMFORT 396 0.0065
818 HYPERKALAEMIA 227 0.0065
819 LYMPHADENOPATHY 229 0.0065
820 DRUG DOSE OMISSION 1068 0.0065
821 DRUG PRESCRIBING ERROR 124 0.0064
822 LUNG INFECTION 100 0.0064
823 MEDICATION ERROR 357 0.0064
824 INTESTINAL OBSTRUCTION 242 0.0064
825 AGEUSIA 160 0.0064
826 DRUG DISPENSING ERROR 98 0.0064
827 PYREXIA 2218 0.0064
828 MELAENA 141 0.0064
829 BLOOD GLUCOSE DECREASED 306 0.0064
830 RASH GENERALISED 165 0.0064
831 ACCIDENTAL OVERDOSE 233 0.0064
832 DRUG EFFECT INCOMPLETE 231 0.0064
833 APHONIA 88 0.0063
834 LABORATORY TEST ABNORMAL 186 0.0063
835 WHITE BLOOD CELL COUNT DECREASED 682 0.0063
836 DRUG INEFFECTIVE 8290 0.0063
837 ENCEPHALOPATHY 154 0.0063
838 GOUT 112 0.0062
839 BLISTER 350 0.0062
840 EXPOSURE DURING PREGNANCY 387 0.0062
841 STOMATITIS 377 0.0062
842 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 439 0.0062
843 INTENTIONAL PRODUCT MISUSE 538 0.0061
844 INFECTION 889 0.0061
845 LOCALISED INFECTION 148 0.0061
846 ANAPHYLACTIC REACTION 338 0.0061
847 PERIPHERAL SWELLING 938 0.0061
848 RASH MACULAR 212 0.0061
849 CONTRAINDICATED PRODUCT ADMINISTERED 183 0.0060
850 THERAPEUTIC RESPONSE DECREASED 366 0.0060
851 COVID-19 1057 0.0060
852 PLATELET COUNT DECREASED 639 0.0060
853 URTICARIA 1004 0.0060
854 MULTIPLE FRACTURES 98 0.0060
855 ACUTE KIDNEY INJURY 911 0.0059
856 CEREBRAL HAEMORRHAGE 213 0.0059
857 OSTEONECROSIS OF JAW 147 0.0059
858 OCULAR HYPERAEMIA 281 0.0059
859 GENERAL PHYSICAL HEALTH DETERIORATION 682 0.0059
860 ORAL HERPES 115 0.0059
861 COMPLICATION OF DEVICE INSERTION 117 0.0059
862 JAUNDICE 158 0.0059
863 FACE OEDEMA 99 0.0059
864 RASH 2558 0.0059
865 TASTE DISORDER 119 0.0059
866 GAIT INABILITY 196 0.0059
867 COMPLICATION OF DEVICE REMOVAL 106 0.0059
868 HYPOACUSIS 252 0.0058
869 RASH PAPULAR 131 0.0058
870 LACRIMATION INCREASED 176 0.0058
871 CONJUNCTIVITIS 108 0.0058
872 FRACTURE 110 0.0058
873 C-REACTIVE PROTEIN INCREASED 211 0.0058
874 DEVICE RELATED INFECTION 89 0.0058
875 PRODUCT USE COMPLAINT 91 0.0058
876 INFUSION RELATED REACTION 382 0.0058
877 DRUG ADMINISTRATION ERROR 176 0.0057
878 ERYTHEMA 1177 0.0057
879 INJECTION SITE URTICARIA 140 0.0057
880 LIP SWELLING 188 0.0056
881 PRODUCT USE IN UNAPPROVED INDICATION 1394 0.0056
882 PRODUCT DOSE OMISSION 367 0.0056
883 PAIN OF SKIN 151 0.0056
884 ISCHAEMIC STROKE 100 0.0056
885 PRODUCT DOSE OMISSION ISSUE 1633 0.0055
886 PRODUCT ADMINISTRATION ERROR 112 0.0055
887 TUBULOINTERSTITIAL NEPHRITIS 103 0.0055
888 RHEUMATOID ARTHRITIS 621 0.0055
889 STEVENS-JOHNSON SYNDROME 121 0.0054
890 METABOLIC ACIDOSIS 172 0.0054
891 THERAPEUTIC RESPONSE SHORTENED 177 0.0053
892 LIVER DISORDER 235 0.0053
893 ILL-DEFINED DISORDER 321 0.0053
894 AGRANULOCYTOSIS 98 0.0053
895 EYE PRURITUS 177 0.0053
896 BLOOD GLUCOSE INCREASED 972 0.0052
897 ACUTE RESPIRATORY DISTRESS SYNDROME 91 0.0051
898 PRODUCT USE ISSUE 965 0.0051
899 PRODUCT QUALITY ISSUE 689 0.0051
900 DRY SKIN 676 0.0051
901 OSTEONECROSIS 166 0.0050
902 THROMBOCYTOPENIA 563 0.0050
903 PRODUCT AVAILABILITY ISSUE 114 0.0050
904 CARDIOVASCULAR DISORDER 126 0.0050
905 GLYCOSYLATED HAEMOGLOBIN INCREASED 125 0.0049
906 CARDIAC FAILURE 395 0.0049
907 CEREBRAL INFARCTION 120 0.0049
908 ECZEMA 257 0.0049
909 HEPATIC FAILURE 148 0.0049
910 SKIN EXFOLIATION 414 0.0049
911 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 84 0.0049
912 HAEMORRHAGE 506 0.0048
913 INJECTION SITE REACTION 333 0.0048
914 SEPTIC SHOCK 210 0.0048
915 INJECTION SITE MASS 178 0.0048
916 INJECTION SITE PRURITUS 321 0.0048
917 ADVERSE EVENT 441 0.0048
918 RASH ERYTHEMATOUS 228 0.0048
919 HEPATOTOXICITY 106 0.0048
920 THERAPEUTIC PRODUCT EFFECT DECREASED 213 0.0048
921 OFF LABEL USE 4162 0.0047
922 ADVERSE DRUG REACTION 426 0.0047
923 COLITIS ULCERATIVE 212 0.0047
924 PSORIASIS 617 0.0047
925 BREAST CANCER FEMALE 126 0.0047
926 INJECTION SITE RASH 144 0.0047
927 SKIN CANCER 101 0.0047
928 PNEUMONITIS 126 0.0046
929 PRODUCT DISPENSING ERROR 100 0.0046
930 APPLICATION SITE ERYTHEMA 120 0.0046
931 INJECTION SITE ERYTHEMA 567 0.0046
932 HYPOCALCAEMIA 86 0.0045
933 THERAPY NON-RESPONDER 203 0.0045
934 SHOCK 103 0.0045
935 PANCYTOPENIA 250 0.0045
936 INJECTION SITE BRUISING 355 0.0044
937 DERMATITIS ATOPIC 233 0.0044
938 INTERSTITIAL LUNG DISEASE 213 0.0044
939 INJECTION SITE PAIN 1347 0.0044
940 INJECTION SITE SWELLING 336 0.0044
941 DEVICE EXPULSION 282 0.0043
942 INCORRECT DRUG ADMINISTRATION DURATION 121 0.0043
943 THERAPY INTERRUPTED 306 0.0043
944 RENAL IMPAIRMENT 357 0.0042
945 LOWER RESPIRATORY TRACT INFECTION 193 0.0042
946 DEVICE BREAKAGE 172 0.0042
947 TRANSAMINASES INCREASED 93 0.0042
948 EYE IRRITATION 240 0.0042
949 BONE DENSITY DECREASED 130 0.0041
950 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 746 0.0041
951 DRUG DEPENDENCE 662 0.0041
952 HOSPITALISATION 625 0.0041
953 INCORRECT DOSE ADMINISTERED 923 0.0040
954 LUNG NEOPLASM MALIGNANT 165 0.0040
955 PRODUCT PRESCRIBING ERROR 95 0.0040
956 SKIN BURNING SENSATION 283 0.0039
957 PSORIATIC ARTHROPATHY 159 0.0039
958 LEUKOPENIA 194 0.0039
959 RASH MACULO-PAPULAR 86 0.0039
960 NEOPLASM MALIGNANT 254 0.0038
961 SYSTEMIC LUPUS ERYTHEMATOSUS 134 0.0038
962 DEVICE ISSUE 337 0.0038
963 INJECTION SITE HAEMORRHAGE 297 0.0037
964 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 752 0.0037
965 APPLICATION SITE PRURITUS 84 0.0037
966 UNDERDOSE 266 0.0036
967 LACTIC ACIDOSIS 118 0.0036
968 DISEASE PROGRESSION 425 0.0036
969 ACNE 270 0.0036
970 NO ADVERSE EVENT 630 0.0035
971 NEUTROPENIA 471 0.0035
972 ANAPHYLACTIC SHOCK 89 0.0034
973 DEVICE MALFUNCTION 239 0.0034
974 NEUTROPHIL COUNT DECREASED 138 0.0034
975 NEEDLE ISSUE 98 0.0034
976 BREAST CANCER 301 0.0032
977 MUCOSAL INFLAMMATION 84 0.0032
978 EXPIRED PRODUCT ADMINISTERED 106 0.0032
979 HEPATIC FUNCTION ABNORMAL 118 0.0032
980 PLASMA CELL MYELOMA 121 0.0031
981 EXTRA DOSE ADMINISTERED 122 0.0030
982 FEBRILE NEUTROPENIA 198 0.0030
983 DEATH 2524 0.0029
984 NEOPLASM PROGRESSION 100 0.0029
985 SKIN IRRITATION 129 0.0028
986 PRODUCT ADHESION ISSUE 99 0.0028
987 MALIGNANT NEOPLASM PROGRESSION 244 0.0024
988 TREATMENT FAILURE 197 0.0024
989 DEVICE LEAKAGE 98 0.0023
990 DEPENDENCE 106 0.0019
991 ACCIDENTAL EXPOSURE TO PRODUCT 189 0.0018
992 DEVICE DIFFICULT TO USE 97 0.0015